Correlation Between Pfizer and ALSP Orchid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and ALSP Orchid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ALSP Orchid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ALSP Orchid Acquisition, you can compare the effects of market volatilities on Pfizer and ALSP Orchid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ALSP Orchid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ALSP Orchid.

Diversification Opportunities for Pfizer and ALSP Orchid

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and ALSP is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ALSP Orchid Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALSP Orchid Acquisition and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ALSP Orchid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALSP Orchid Acquisition has no effect on the direction of Pfizer i.e., Pfizer and ALSP Orchid go up and down completely randomly.

Pair Corralation between Pfizer and ALSP Orchid

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the ALSP Orchid. In addition to that, Pfizer is 9.45 times more volatile than ALSP Orchid Acquisition. It trades about -0.08 of its total potential returns per unit of risk. ALSP Orchid Acquisition is currently generating about 0.18 per unit of volatility. If you would invest  1,024  in ALSP Orchid Acquisition on September 3, 2024 and sell it today you would earn a total of  44.00  from holding ALSP Orchid Acquisition or generate 4.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy30.91%
ValuesDaily Returns

Pfizer Inc  vs.  ALSP Orchid Acquisition

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
ALSP Orchid Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALSP Orchid Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, ALSP Orchid is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pfizer and ALSP Orchid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and ALSP Orchid

The main advantage of trading using opposite Pfizer and ALSP Orchid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ALSP Orchid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALSP Orchid will offset losses from the drop in ALSP Orchid's long position.
The idea behind Pfizer Inc and ALSP Orchid Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon